Abstracts reviewed not cited 151-241

Abstracts that have been reviewed but not cited are included for information purposes.

151.	Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O'Connell TN, Zandi KS, Miller S, Coe JW. Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro. Drug Metab Dispos. 2006 Jan;34(1):121-30. Epub 2005 Oct 12.
152.	O’Donnell DE, Parker CM. COPD exacerbations. 3: Pathophysiology. Thorax 2006;61(4):354-61
153.	Oh H, Seo W. Meta-analysis of the effects of respiratory rehabilitation programmes on exercise capacity in accordance with programme characteristics. J Clin Nurs. 2007 Jan;16(1):3-15
154.	Ohno Y, Iwasawa T, Seo JB, Koyama H, Takahashi H, Oh YM, Nishimura Y, Sugimura K. Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008 May 15;177(10):1095-102. Epub 2008 Feb 14.
155.	Okamoto LJ. Outcomes and humanistic issues related to treatment of acute bronchospasm. Pharmacotherapy. 2006 Sep;26(9 Pt 2):175S-80S
156.	Okuyemi KS, Nollen NL, Ahluwalia JS. Interventions to facilitate smoking cessation. Am Fam Physician. 2006 Jul 15;74(2):262-71.
157.	Oncken C, Watsky E, Reeves K, Anziano R. Efficacy and safety of the novel selective nicotinic receptor partial agonist varenicline for smoking cessation. Journal of the American College of Cardiology 2005; 45(3 Suppl A): 381A
158.	Oncken C, Watsky E, Reeves K, Anziano R. Smoking cessation with varenicline, a selective nicotinic receptor partial agonist: results from a Phase 2 study. Society for Research on Nicotine and Tobacco 11th Annual Meeting, 20-23 March 2005; Prague, Czech Republic 2005
159.	Oncken C, Watsky E, Reeves K, Anziano R. Varenicline is efficacious and well tolerated in promoting smoking cessation: results from a 7-week, randomized, placebo- and bupropion-controlled trial. Society for Research on Nicotine and Tobacco 11th Annual Meeting, 20-23 March 2005; Prague, Czech Republic 2005
160.	Padula CA, Yeaw E. Inspiratory muscle training: integrative review. Res Theory Nurs Pract. 2006 Winter;20(4):291-304
161.	Padula CA, Yeaw E. Inspiratory muscle training: integrative review of use in conditions other than COPD.Res Theory Nurs Pract. 2007;21(2):98-118
162.	Pierson DJ. Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources. Respir Care 2006;51(3):277-88
163.	Pisinger C, Godtfredsen NS. Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine Tob Res. 2007 Jun;9(6):631-46.
164.	Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R. Are patients with COPD more active after pulmonary rehabilitation? Chest. 2008 Aug;134(2):273-80. Epub 2008 Apr 10
165.	Polley L, Yaman N, Heaney L, Cardwell C, Murtagh E, Ramsey J, Macmahon J, Costello RW, McGarvey L. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest. 2008 Aug;134(2):295-302. Epub 2007 Dec 10.
166.	Poole P J, Black P N. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review (Brief record). BMJ 2001; 322: 1271-1274
167.	Potts LA, Garwood CL. Varenicline: the newest agent for smoking cessation. Am J Health Syst Pharm. 2007 Jul 1;64(13):1381-4.
168.	Puhan MA, Schünemann HJ, Buesching G, vanOort E, Spaar A, Frey M. COPD patients' ability to follow exercise influences short-term outcomes of rehabilitation. Eur Respir J. 2008 Feb;31(2):304-10. Epub 2007 Nov 7.
169.	Puhan MA, Schunemann HL, Frey M, Bachmann LM. Value of supplemental interventions to enhance the effectiveness of physical exercise during respiratory rehabilitation in COPD patients: a systematic review (Provisional record). Respiratory Research 2004;5:25
170.	Putt MT, Watson M, Seale H, Paratz JD. Muscle stretching technique increases vital capacity and range of motion in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2008 Jun;89(6):1103-7
171.	Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007 Nov 6;147(9):633-8.
172.	Ram FSF, Barnes NC, Granados-Navarrete A, Garcia-Aymerich J, Sestini P, Melani AS, Rodriguez-Roisin R. Comparing antibiotics for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews: Protocols 2008 Issue 2 John Wiley & Sons, Ltd Chichester, UK DOI: 10.1002/14651858.CD007093
173.	Ranney L, Melvin C, Lux L, McClain E, Lohr KN. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med. 2006 Dec 5;145(11):845-56. Epub 2006 Sep 5.
174.	Reeves KR, Watsky E, Williams KE, Azoulay S, Billing CB, Gong J. The safety of varenicline in cigarette smokers following a 52-week treatment period (RPOS 3-54). Society for Research on Nicotine and Tobacco 12th Annual Meeting February 15-18, Orlando, Florida 2006: 15
175.	Reid RD, Quinlan B, Riley DL, Pipe AL. Smoking cessation: lessons learned from clinical trial evidence. Curr Opin Cardiol. 2007 Jul;22(4):280-5.
176.	Reus VI, Obach RS, Coe JW, Faessel H, Rollema H, Watsky E, Reeves K. Varenicline: new treatment with efficacy in smoking cessation. Drugs Today (Barc). 2007 Feb;43(2):65-75.
177.	Restrepo RD. Use of inhaled anticholinergic agents in obstructive airway disease.Respir Care. 2007 Jul;52(7):833-51
178.	Rice KL, Leimer I, Kesten S, Niewoehner DE. Responses to tiotropium in African-American and Caucasian patients with chronic obstructive pulmonary disease. Transl Res. 2008 Aug;152(2):88-94. Epub 2008 Jun 23.
179.	Robert D, Argaud L. Clinical review: long-term noninvasive ventilation. Crit Care. 2007;11(2):210.
180.	Rogers AV, Adelroth E, Hattotuwa K, Dewar A, Jeffery PK. Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study. Thorax. 2008 Feb;63(2):108-14. Epub 2007 Sep 17.
181.	Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology. 2007 Mar;52(3):985-94. Epub 2006 Dec 8.
182.	Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci. 2007 Jul;28(7):316-25. Epub 2007 Jun 18.
183.	Rutten FH, Vonken EJ, Cramer MJ, Moons KG, Velthuis BB, Prakken NH, Lammers JW, Grobbee DE, Mali WP, Hoes AW. Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease. Am Heart J. 2008 Sep;156(3):506-12. Epub 2008 Jun 17.
184.	Salpeter S R, Ormiston T M, Salpeter E E, Poole P J, Cates C J. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis (Brief record). Respiratory Medicine 2003;97(10):1094-1101
185.	Sanabria A, Valdiviesco E, Gomez G, Echeverry G. Prophylactic antibiotics in chest trauma: a meta-analysis of high-quality studies. World J Surg 2006;30(10):1843-7
186.	Schmier JK, Halpern MT, Jones ML. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence (Provisional record). Drugs and Aging 2005;22(9):717-719
187.	Schnoll RA, Patterson F, Lerman C. Treating tobacco dependence in women. J Womens Health (Larchmt). 2007 Oct;16(8):1211-8.
188.	Sekine Y, Kesler KA, Behnia M, Brooks-Brunn J, Sekine E, Brown JW. COPD may increase the incidence of refractory supraventricular arrhythmias following pulmonary resection for non-small cell lung cancer. Chest 2001 Dec;120(6):1783-90
189.	Sessler CN, Cohen MD. Cardiac arrhythmias during theophylline toxicity. A prospective continuous electrocardiographic study. Chest 1990 Sep;98(3):672-8
190.	Shetty R, Seddighzadeh A, Piazza G, Goldhaber SZ. Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination. J Thromb Thrombolysis. 2008 Aug;26(1):35-40. Epub 2007 Oct 17.
191.	Shukla VK, Husereau DR, Boucher M, Mensinkai S, Dales R. Long-acting beta2-agonists for maintenance therapy of stable chronic obstructive pulmonary disease: a systematic review. (Structured Abstract) 2002:39
192.	Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Gan WQ, Rousseau R; ABC(Advair, Biomarkers in COPD) Investigators. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008 Jun 1;177(11):1207-14. Epub 2008 Feb 28.
193.	Singh SJ, Jones PW, Evans R, Morgan MD. Minimum clinically important improvement for the incremental shuttle walking test. Thorax. 2008 Sep;63(9):775-7. Epub 2008 Apr 4.
194.	Siu EC, Tyndale RF. Non-nicotinic therapies for smoking cessation. Annu Rev Pharmacol Toxicol. 2007;47:541-64.
195.	Smith J, Woodcock A. Cough and its importance in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(3):305-14
196.	Sobieraj DM, White CM, Coleman CI. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther. 2008 Aug;30(8):1416-25.
197.	Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease,chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006 Jan;31(1):58-69
198.	Soriano JB, Sin DD, Zhang X, Camp PG, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Petersson S, Postma DS, Szafranski W, Vestbo J. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest. 2007 Mar;131(3):682-9
199.	Spencer S, Evans D. Inhaled corticosteroids versus long acting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews: Protocols 2008 Issue 2 John Wiley & Sons, Ltd Chichester, UK DOI: 10.1002/14651858.CD007033
200.	Spencer LM, Alison JA, McKeough ZJ. Six-minute walk test as an outcome measure: are two six-minute walk tests necessary immediately after pulmonary rehabilitation and at three-month follow-up? Am J Phys Med Rehabil. 2008 Mar;87(3):224-8.
201.	Sridhar M, Taylor R, Dawson S, Roberts NJ, Partridge MR. A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2008 Mar;63(3):194-200. Epub 2007 Sep 27.
202.	Stack NM. Smoking cessation: an overview of treatment options with a focus on varenicline. Pharmacotherapy. 2007 Nov;27(11):1550-7.
203.	Stead LF, Lancaster T. Nicobrevin for smoking cessation. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005990.
204.	Steele BG, Belza B, Cain KC, Coppersmith J, Lakshminarayan S, Howard J, Haselkorn JK. A randomized clinical trial of an activity and exercise adherence intervention in chronic pulmonary disease. Arch Phys Med Rehabil. 2008 Mar;89(3):404-12.
205.	Steentoft J, Konradsen HB, Hilskov J, Gislason G, Andersen JR. Response to pneumococcal vaccine in chronic obstructive lung disease--the effect of ongoing, systemic steroid treatment. Vaccine 2006 Feb 27;24(9):1408-12
206.	Stoloff S, Samuels S, Kerney D, Brown CP. Management of chronic obstructive pulmonary disease associated with chronic bronchitis with inhaled fluticasone propionate/salmeterol (ADVAIR DISKUS) 250/50: results of a patient experience trial. MedGenMed. 2006 Mar 29;8(1):86
207.	Stolz D, Breidthardt T, Christ-Crain M, Bingisser R, Miedinger D, Leuppi J, Mueller B, Tamm M, Mueller C. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest. 2008 May;133(5):1088-94. Epub 2008 Mar 13.
208.	Stull DE, Leidy NK, Jones PW, Ståhl E. Measuring functional performance in patients with COPD: a discussion of patient-reported outcome measures. Curr Med Res Opin. 2007 Nov;23(11):2655-65.
209.	Sutherland ER, Crapo JD, Bowler RP. N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease. COPD. 2006 Dec;3(4):195-202
210.	Swartz S, Gonzales D, Billing CB, Watsky E, Gong J, Williams K, Reeves K. The effect of nicotine dependence level on quit outcomes with varenicline: results from a pooled-analysis of controlled trials (PA11-1). Society for Research on Nicotine and Tobacco 13th Annual Meeting February 21-24, Austin, Texas 2007:3
211.	Taylor AH, Ussher MH, Faulkner G. The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect and smoking behaviour: a systematic review. Addiction. 2007 Apr;102(4):534-43.
212.	Taylor NF, Dodd KJ, Shields N, Bruder A. Therapeutic exercise in physiotherapy practice is beneficial: a summary of systematic reviews 2002-2005. Aust J Physiother. 2007;53(1):7-16
213.	Thabut G, Christie JD, Ravaud P, Castier Y, Brugière O, Fournier M, Mal H, Lesèche G, Porcher R. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet. 2008 Mar 1;371(9614):744-51
214.	Thomas GS, Tammelin BR, Schiffman GL, Marquez R, Rice DL, Milikien D, Mathur V. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol. 2008 May-Jun;15(3):319-28. Epub 2008 Apr 14.
215.	Tinker R, While A. Promoting quality of life for patients with moderate to severe COPD. Br J Community Nursing 2006;11(7):278-84
216.	Tong EK, Carmody TP, Simon JA. Bupropion for smoking cessation: a review. Compr Ther. 2006 Spring;32(1):26-33.
217.	Tonstad S. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist. J Cardiovasc Nurs. 2006 Nov-Dec;21(6):433-6.
218.	Tonstad S. Varenicline for smoking cessation. Expert Rev Neurother. 2007 Feb;7(2):121-7.
219.	Travers J, Marsh S, Caldwell B, Williams M, Aldington S, Weatherall M, Shirtcliffe P, Beasley R. External validity of randomized controlled trials in COPD. Respir Med. 2007 Jun;101(6):1313-20. Epub 2006 Nov 17
220.	Tsai YH, Lee CJ, Lan RS, Lee CH. Multifocal atrial tachycardia as a prognostic indicator in patients with severe chronic obstructive pulmonary disease requiring mechanical ventilation. Changgeng Yi Xue Za Zhi 1991 Sep;14(3):163-7
221.	Tukek T, Yildiz P, Akkaya V, Karan MA, Atilgan D, Yilmaz V, Korkut F. Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion. Ann Noninvasive Electrocardiol 2002 Jul;7(3):222-7
222.	Ueng KC, Lee SH, Wu DJ, Lin CS, Chang MS, Chen SA. Radiofrequency catheter modification of atrioventricular junction in patients with COPD and medically refractory multifocal atrial tachycardia. Chest 2000 Jan;117(1):52-9
223.	Urbano FL, Pasqual RM. Contemporary issues in the care of patients with chronic obstructive pulmonary disease. J Manag Care Pharm 2005;11(5 Suppl A):S2-13; quiz S14-6
224.	Uronis HE, McCrory DC, Samsa GP, Currow DC, Abernethy AP. Palliative oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews: Protocols 2007 Issue 2 John Wiley & Sons, Ltd Chichester, UK DOI: 10.1002/14651858.CD006429
225.	van den Bemt L, Schermer T, Smeele I, Bischoff E, Jacobs A, Grol R, van Weel C. Monitoring of patients with COPD: a review of current guidelines' recommendations. Respir Med. 2008 May;102(5):633-41. Epub 2008 Jan 31.
226.	van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JC, Kingma JH, Sturkenboom MC, Stricker BH. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med 2006 May 8;166(9):1016-20
227.	Varenicline (CHANTIX): a stop-smoking pill. ORL Head Neck Nurs. 2006 Fall;24(4):18-9.
228.	Vidrine JI, Cofta-Woerpel L, Daza P, Wright KL, Wetter DW. Smoking cessation 2: behavioral treatments. Behav Med. 2006 Fall;32(3):99-109.
229.	Wallace LD, Troy KE. Office-based spirometry for early detection of obstructive lung disease. J Am Acad Nurse Pract 2006;18(9):414-21
230.	White RD. Prehospital recognition of multifocal atrial tachycardia: association with acute myocardial infarction. Ann Emerg Med 1992 Jun;21(6):753-6
231.	Whitley HP, Moorman KL. Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine. Pharmacotherapy. 2007 Oct;27(10):1440-5.
232.	Williams KE, Reeves KR, Billing CB Jr, Pennington AM, Gong J. A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Curr Med Res Opin. 2007 Apr;23(4):793-801.
233.	Williams M, Cafarella P, Olds T, Petkov J, Frith P. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest. 2008 Sep;134(3):489-96. Epub 2008 May 19.
234.	Williams MV, Huddleston J, Whitford K, DiFrancesco L, Wilson M. Advances in hospital medicine: a review of key articles from the literature. Med Clin North Am 2002 Jul;86(4):797-823
235.	Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res. 2007 Jan;9(1):21-32.
236.	Wise RA, Tashkin DP. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies. Am J Med. 2007 Aug;120(8 Suppl 1):S4-13
237.	Wise RA, Tashkin DP. Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient? Am J Med. 2007 Aug;120(8 Suppl 1):S14-22.
238.	Yacoub WG, Reisz G. Kicking butts: smoking cessation update. Mo Med. 2007 May-Jun;104(3):260-4.
239.	Zacarias EC, Castro AA, Cendon S. Effect of theophylline associated with short-acting or long-acting inhaled beta2-agonists in patients with stable chronic obstructive pulmonary disease: a systematic review. J Bras Pneumol. 2007 Apr;33(2):152-60.
240.	Zierler-Brown SL, Kyle JA. Oral varenicline for smoking cessation. Ann Pharmacother. 2007 Jan;41(1):95-9. Epub 2006 Dec 26.
241.	Zwar N, Hermiz O, Hasan I, Comino E, Middleton S, Vagholkar S, Marks G. A cluster randomised controlled trial of nurse and GP partnership for care of chronic obstructive pulmonary disease. BMC Pulm Med. 2008 Jun 3;8:8.

< Prev